肺高血压的更新血液动力学定义和分类
Benoit Lechartier1,2,3,4, Mithum Kularatne1,2,3,5, Xavier Jaïs1,2,3,6
1Department of Respiratory and Intensive Care Medicine, Pulmonary Hypertension National Referral Center, Assistance Publique-Hôpitaux de Paris (AP-HP), Hôpital Bicêtre, Le Kremlin-Bicêtre, France.
Seminars in respiratory and critical care medicine
|August 18, 2023
概括
欧洲心脏病学会 (ESC) 和欧洲呼吸学会 (ERS) 的2022年指导方针更新了肺高血压 (PH) 诊断,将平均肺动脉压力 (mPAP) 门降至20 mm Hg. 这影响了毛囊前PH定义和临床分类.
科学领域:
- 心脏病学 心脏病学
- 肺部病理学 肺部病理学
- 医学指导方针 医学指导方针
背景情况:
- 肺高血压 (PH) 是一种复杂的疾病,由肺动脉压升高来定义.
- 诊断传统上依赖于右心脏导管.
- 之前的定义要求平均肺动脉压力 (mPAP) >20 mm Hg.
研究的目的:
- 概述PH的更新血液动力学定义.
- 详细介绍PH的修订后的临床分类.
- 突出了2022年ESC/ERS指南所引入的变化.
主要方法:
- 审查2022年欧洲心脏病学会 (ESC) 和欧洲呼吸学会 (ERS) 准则.
- 对PH诊断的新血液动力学标准的分析.
- 检查更新的临床分类系统.
主要成果:
- 新的血液动力学定义将mPAP值降低到PH诊断的Hg>20毫米.
- 前毛细管PH现在定义为mPAP>20 mm Hg,肺动脉压<15 mm Hg,肺血管阻力>2木单位.
- 这些指南引入了PH的修订后的临床分类,保持了基于病理生理学的五组结构.
结论:
- 更新的ESC/ERS 2022指南提供了肺高血压的精细血液动力学定义.
- 这些变化影响了诊断标准,特别是毛囊前PH.
- 修订后的分类有助于理解PH的多样性病理生理学.
相关概念视频
Pulmonary Hypertension: Classification and Pathogenesis
222
Pulmonary hypertension (PH) is a severe health condition in which the mean pulmonary arterial pressure increases to 25 mmHg or more, even when the body is at rest. This high pressure in the blood vessels that transport blood from the heart to the lungs can cause various symptoms, including shortness of breath, can lead to right heart failure, and significantly affect the overall quality of life.
There are various classifications for PH, each relating to different underlying causes and also...
There are various classifications for PH, each relating to different underlying causes and also...
222
Pathophysiology of Heart Failure
1.6K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
1.6K
Hypertension I: Introduction
16
Hypertension is a widespread, long-term medical condition where blood pressure in the arteries remains elevated. It is characterized by systolic blood pressure readings of 130 mm Hg or above or diastolic blood pressure (DBP) readings of 80 mm Hg or higher. Unmanaged hypertension poses significant health risks, making the distinction between primary (or essential) hypertension and secondary hypertension crucial, as their management and implications vary.Primary HypertensionPrimary hypertension,...
16
Pulmonary Embolism I: Introduction
7
Pulmonary embolism (PE) occurs when a thrombus, fat or air embolus, amniotic fluid, or tumor tissue blocks one or more pulmonary arteries. These blockages originate in the venous system or the right side of the heart.EtiologyPE primarily arises from deep vein thrombosis (DVT) and other hypercoagulable states, such as inherited thrombophilias. Additional etiological factors include venous stasis, commonly seen in obesity, and endothelial injury from surgery and trauma. Less common causes include...
7
Heart Failure IV: Classification and Diagnostic Evaluation
19
Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...
19
Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists
201
Endothelins (ETs) are potent vasoactive peptides critical in the human body's various physiological and pathological processes. One of the most promising therapeutic strategies for treating pulmonary arterial hypertension (PAH) involves counteracting the effects of these endothelins using a class of drugs known as endothelin receptor antagonists.
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...
201


